Editorial: Metabolic cell death in cancer: innovative therapeutic avenues for cancer treatment - Takeaways - MDSpire

Editorial: Metabolic cell death in cancer: innovative therapeutic avenues for cancer treatment

  • By

  • Zhou Yang

  • Guang Lei

  • Yize Li

  • June 9, 2026

  • 0 min

Share

  • 1

    Metabolic reprogramming is a hallmark of cancer that influences tumor survival and susceptibility to regulated cell death.

  • 2

    Serine metabolism exemplifies how cancer cells balance biosynthetic demands and survival, highlighting serine dependency as a metabolic liability.

  • 3

    Hypoxia drives metabolic adaptation and resistance to cell death, with HIF-1α being a critical regulator of cell death susceptibility.

  • 4

    Genetic context shapes metabolic vulnerabilities, suggesting that specific tumor subtypes may have unique metabolic dependencies.

  • 5

    Ferroptosis is an emerging therapeutic opportunity, with factors like TIMP1 influencing sensitivity in colorectal cancer.

Original Source(s)

Editorial: Metabolic cell death in cancer: innovative therapeutic avenues for cancer treatment

  • by Zhou Yang, Guang Lei, Yize Li

  • June 9, 2026

Related Content

Neurofilament light and glial fibrillary acidic protein do not reflect neuronal or glial damage during different intracranial radiotherapy regimes: a pilot study

An exploratory integrative analysis of plasma transcriptomic and proteomic predictors of response to total neoadjuvant therapy in locally advanced rectal cancer

Early risk stratification and temporal biomarker patterns of trousseau syndrome-related cerebral infarction in lung cancer